Skip to main content
. 2019 Sep 6;7:e7627. doi: 10.7717/peerj.7627

Figure 5. DNLA reduced the accumulation of Aβ through non-amyloidogenic pathways.

Figure 5

The protein expression levels of ADAM17 (B) and ADAM10 (C) as determined from densitometric scans of Western blots analyses. DNLA significantly decreased the protein expression of ADAM10 (35, 350, 700 ng/mL). However, this treatment significantly increased the protein expression of ADAM17 (0.35 ng/mL). (A) Representative strips of these proteins. Data are presented as the mean ± SD (n = 4). *P < 0.05 versus the sham group.